Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Radiol Clin North Am. 2021 Sep;59(5):875–886. doi: 10.1016/j.rcl.2021.05.010

Figure 4.

Figure 4.

Pancreatitis in a 57-year-old woman with metastatic anal cancer on nivolumab. Fused FDG PET/CT (A) and CT (B) images acquired 7.5 months after initiation of treatment demonstrate increased FDG uptake in an edematous pancreas (arrows); the patient had diarrhea at the time of the scan. Nivolumab was held for one cycle and pancreatic enzyme supplementation was started. A follow up contrast-enhanced CT (C) performed 9 months later showed resolution with interval atrophy of the pancreas. Chronic right-sided hydronephrosis is also seen.